Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Apyx Medical Tightens FY24 Total Revenue Outlook From $49.7M - $52.9M To $50.6M - $52.1M, Est $49.99M

Author: Benzinga Newsdesk | August 08, 2024 05:51pm

Posted In: APYX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist